Alendronate sodium demonstrates significant clinical advantages in treating osteoporosis secondary to severe fractures

Alendronate sodium significantly improves clinical outcomes in treating patients with osteoporosis secondary to severe fractures.

Authors

Institutions

Publication Details

Journal
American Journal of Translational Research
Published
2025-01-01
DOI
https://doi.org/10.62347/mfpv8667
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alendronate sodium demonstrates significant clinical advantages in treating osteoporosis secondary to severe fractures

Shenggen Wang
American Journal of Translational Research
Bone health and treatments
article

Alendronate sodium demonstrates significant clinical advantages in treating osteoporosis secondary to severe fractures

Shenggen Wang
article en

Abstract

Alendronate sodium significantly improves clinical outcomes in treating patients with osteoporosis secondary to severe fractures.

American Journal of Translational ResearchVol. 17(6)
Xinyu University (CN)
Zero hunger
Openalex Percentile: Top 77%
Bone health and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Alendronate sodium demonstrates significant clinical advantages in treating osteoporosis secondary to severe fractures — Shenggen Wang · American Journal of Translational Research (2025) | TGRS Research Map | TGRS